Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network

Omar Abdelhalim; Mohammed Y. Youssef; Sawsan Al-Lababidi; Mohamed Eldesouki; Ahmed Mohamed; Mohammed Abusuliman; Mahmoud Nassar; Mohammad Abushanab; Ahmed Salem; Hassan Shaheen; Ahmed Aref; Khaled M. Elhusseiny; Chloe Lahoud; Zara Bhutta; Hazem Abosheaishaa

doi:10.21037/atm-2026-0131

Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network

Annals of translational medicine · Published 2026-06-01 · Journal article · DOI 10.21037/atm-2026-0131

Authors (15)

Omar Abdelhalim, Mohammed Y. Youssef, Sawsan Al-Lababidi, Mohamed Eldesouki, Ahmed Mohamed, Mohammed Abusuliman, Mahmoud Nassar, Mohammad Abushanab, Ahmed Salem, Hassan Shaheen, Ahmed Aref, Khaled M. Elhusseiny, Chloe Lahoud, Zara Bhutta, Hazem Abosheaishaa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume: 14
Issue: 3
Pages: 32-32
Year: 2026

Citation

Abdelhalim, O., Youssef, M., Al-Lababidi, S., et al. (2026). Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network. Annals of translational medicine. https://doi.org/10.21037/atm-2026-0131